Recovery is one story. Tissue quality is the other.
A compounded four-peptide prescription built around two stories: recovery and the quality of the tissue being rebuilt.
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
About 10 minutes. No charge unless your clinician approves.
Healing is not only about closing the injury.
The body can finish the obvious part of healing and still leave behind tissue that does not behave like what it replaced. Scar quality, collagen organization, blood supply, inflammatory signaling, and cell movement all shape what happens after an injury has technically closed.
This combination approaches that second phase from four different directions.
GHK-Cu carries copper, and your body releases it from SPARC as the scaffolding between cells is being rebuilt.1 In fibroblast cultures, research shows the copper complex increases the amount of collagen each repair cell produces rather than simply making more cells,2 and shifts gene activity in human connective tissue toward the pattern of healthier tissue.3 BPC-157, KPV, and TB-500 add research around blood-vessel formation, inflammatory signaling, and the movement of cells involved in repair.4567
That is the reason for the four-part design. Not one molecule asked to do everything, but several parts of the repair environment addressed in the same prescription.
The four components divide into two biological layers. BPC-157 and TB-500 sit in recovery research, while GHK-Cu and KPV add connective-tissue and inflammatory-signaling research.
- Lane TF, et al. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol. 1994.PubMed
- Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the… FEBS Lett. 1988.PubMed
- Campbell JD, et al. A gene expression signature of emphysema-related lung destruction and… Genome Med. 2012. Human tissue gene expression and cell culture; GHK was not administered to people in this study.PubMed
- Hsieh MJ, et al. J Mol Med. 2017.
- Malinda KM, et al. FASEB J. 1997.
- Philp D, et al. FASEB J. 2003.PubMed
- Dalmasso G, et al. Gastroenterology. 2008.PubMed
For when the injury is over, but the tissue still tells the story.
Healed, But Different
The injury closed. The pain may even be mostly gone. What remains is tissue that feels tighter, weaker, or less cooperative than what was there before.
The Recovery That Changed With Age
The injury you once shrugged off now asks for a real plan. You are less interested in pretending recovery works the same at fifty as it did at thirty.
Scar Tissue Became the Limiter
The procedure succeeded and the scar did what scars are supposed to do. Now the quality and behavior of the tissue around it are what matter.
Compounded BPC-157 / GHK-Cu / KPV / TB-500 is not an FDA-approved drug product. Whether it is appropriate for you is determined by a licensed provider from your full Assessment.
This might not be the right fit if:
- Active or suspected malignancy, or a history of cancer without oncology clearance
- Pregnancy or breastfeeding
- Known hypersensitivity to any component of the preparation
- Under 18
- Wilson disease or any other disorder of copper handling
- An active infection that has not been treated
- Competing in a tested sport, unless you have confirmed the position with your governing body
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
KLOW Stack, prescribed with care.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
- Four distinct peptide components selected around different parts of the tissue-repair environment
- A licensed provider reviews the injury, medical history, medications, and full combination before prescribing
- Dose and duration are set for you, with follow-up built into the plan
- Provider review, the prescription if approved, pharmacy, and shipping handled inside one plan.
Compounded by a licensed US pharmacy to an individual prescription. Compounded preparations are not FDA-approved drug products.
*Price reflects a 3 month commitment. Other billing options are shown at checkout.
More in Recovery & Repair.
BPC-157
The peptide everyone asks about, inside real medicine.
Compounded BPC-157 sourced through a licensed US pharmacy and placed inside clinician review, not a research-vendor checkout.
BPC-157 Oral
A capsule that meets the digestive tract directly.
Compounded oral BPC-157 delivered directly into the digestive tract, with a clinician deciding whether capsule or injection fits the case.
Wolverine Stack
Two repair pathways. One prescription.
A compounded BPC-157 and TB-500 prescription pairing BPC-157's tissue-repair signaling with thymosin beta-4 biology in cell movement and wound closure.
Do not use if you have
- Wilson disease or any other disorder of copper handling
- Active or suspected malignancy
- An untreated active infection
Serious risks
- GHK-Cu delivers copper, and copper accumulates
- BPC-157 acts on blood vessel formation
- Thymosin beta-4 has been shown in laboratory work to push colon cancer cells toward the mobile, invasive state that precedes spread8
- KPV turns down part of the inflammatory response, so it is not started during an untreated active infection
- BPC-157 and TB-500 are prohibited at all times by the World Anti-Doping Agency, in and out of competition
Commonly reported
- Mostly local: soreness, redness or swelling where you inject
Three things drive the screening. Any history of cancer is screened carefully, and your provider will want to know about copper you already take. Human safety data is limited, which is the reason this sits with a clinician rather than in a shopping cart. If you are a tested athlete, say so at intake.
- Huang HC, et al. Oncogene. 2007.
Asked and answered.
You are not charged, and you are not left guessing. Your clinician explains the reasoning and, where it helps, what a better path might look like. Reviews are typically completed in under 24 hours.
The formula is built around two research stories. BPC-157 and TB-500 sit in the recovery conversation, while GHK-Cu and KPV add tissue-quality and inflammation research. Each component carries a different evidence base, and no controlled human trial has established the four-peptide combination as a finished treatment.
In July 2026 an FDA advisory committee voted to recommend three of the four compounds in this preparation for pharmacy compounding. That recommendation is advisory and the agency has not yet acted on it. No compounded medication is FDA-approved, including this one. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product.
A four-component product makes medical accountability more important, not less. Here, a licensed provider decides whether the combination belongs in your care, and a licensed US pharmacy compounds it to your prescription. The FDA has found products sold as research chemicals under false labels, some naming compounding pharmacies that do not exist, and warns they “can pose risks of serious harm” by bypassing the body’s defenses.F4 Testing has found wide variation in purity and in how much of the compound is actually in the vial. If something this biologically complicated is going into your body, the prescription, pharmacy, and clinician around it are not administrative details. They are part of the product.
Any time, before your renewal date. No phone calls required.
- FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, and FDA Warning Letter to Gram Peptides, March 31, 2026.